Janet M Wojcicki1, Deena Elwan1, Jue Lin2, Elizabeth Blackburn2, Elissa Epel3. 1. 1 Department of Pediatrics, University of California , San Francisco, San Francisco, California. 2. 2 Department of Biochemistry and Biophysics, University of California , San Francisco, San Francisco, California. 3. 3 Department of Psychiatry, University of California , San Francisco, San Francisco, California.
Abstract
AIMS: Shorter telomere length is associated with increased chronic disease risk in adulthood including diabetes mellitus and cardiovascular risk. Few studies have evaluated the relationship between telomere length change and incident disease risk in populations with a high percentage of overweight and obesity. RESULTS: In an urban Latina population recruited in San Francisco (n = 82) with a high prevalence of overweight and obesity (78.4%), we assessed leukocyte telomere length and telomere length change over a 1-year period in relation to obesity, chronicity of obesity, and incident metabolic disease risk 5-6 years later. We also assessed the relationship between telomere length change over a 1-year period and weight loss. There were no significant associations between baseline telomere length and socio-demographics including age and ethnicity, or current weight status. Telomere length change, however, was associated with being obese at baseline and previous years of chronic obesity. A high percentage of women who were obese at baseline were also obese the year before (90%) and 2 years before (85%). Obesity at baseline was an independent predictor for increased telomere length attrition (β = -346.9, -568.4 to -125.4; P < 0.01). Similarly, chronic obesity was associated with increased risk for accelerated attrition (β = -280.6, -518.4 to -42.8; P < 0.01). INNOVATION: We speculate that accelerated attrition may be a harbinger of metabolic disease. We also found that those who had or developed hypertension had accelerated attrition [-407.4 ± 464.0 vs. -168.1 ± 643.6 (P = 0.03)]. CONCLUSION: In populations with chronic and long-standing obesity, telomere length attrition rate, rather than baseline telomere length may be a more sensitive indicator of health status including chronic disease development.
AIMS: Shorter telomere length is associated with increased chronic disease risk in adulthood including diabetes mellitus and cardiovascular risk. Few studies have evaluated the relationship between telomere length change and incident disease risk in populations with a high percentage of overweight and obesity. RESULTS: In an urban Latina population recruited in San Francisco (n = 82) with a high prevalence of overweight and obesity (78.4%), we assessed leukocyte telomere length and telomere length change over a 1-year period in relation to obesity, chronicity of obesity, and incident metabolic disease risk 5-6 years later. We also assessed the relationship between telomere length change over a 1-year period and weight loss. There were no significant associations between baseline telomere length and socio-demographics including age and ethnicity, or current weight status. Telomere length change, however, was associated with being obese at baseline and previous years of chronic obesity. A high percentage of women who were obese at baseline were also obese the year before (90%) and 2 years before (85%). Obesity at baseline was an independent predictor for increased telomere length attrition (β = -346.9, -568.4 to -125.4; P < 0.01). Similarly, chronic obesity was associated with increased risk for accelerated attrition (β = -280.6, -518.4 to -42.8; P < 0.01). INNOVATION: We speculate that accelerated attrition may be a harbinger of metabolic disease. We also found that those who had or developed hypertension had accelerated attrition [-407.4 ± 464.0 vs. -168.1 ± 643.6 (P = 0.03)]. CONCLUSION: In populations with chronic and long-standing obesity, telomere length attrition rate, rather than baseline telomere length may be a more sensitive indicator of health status including chronic disease development.
Authors: Scott Brouilette; Ravi K Singh; John R Thompson; Alison H Goodall; Nilesh J Samani Journal: Arterioscler Thromb Vasc Biol Date: 2003-03-20 Impact factor: 8.311
Authors: Sangmi Kim; Christine G Parks; Lisa A DeRoo; Honglei Chen; Jack A Taylor; Richard M Cawthon; Dale P Sandler Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03 Impact factor: 4.254
Authors: Janet M Wojcicki; Katherine Holbrook; Robert H Lustig; Elissa Epel; Aaron B Caughey; Ricardo F Muñoz; Stephen C Shiboski; Melvin B Heyman Journal: PLoS One Date: 2011-02-23 Impact factor: 3.240
Authors: Trygve Lofterød; Hanne Frydenberg; Vidar Flote; Anne Elise Eggen; Anne McTiernan; Elin S Mortensen; Lars A Akslen; Jon B Reitan; Tom Wilsgaard; Inger Thune Journal: Breast Cancer Res Treat Date: 2020-05-20 Impact factor: 4.872
Authors: Sheng-Nan Yu; Shi-Qi Chen; Guo-Quan Fan; Wei-Zhe Pan; Jin Jia; Qian Wang; Li Ma; Ben Li; Mei Qiang; Yu-Lan Qiu; Tong Wang Journal: Biomed Res Int Date: 2020-12-03 Impact factor: 3.411
Authors: Francisco Alejandro Montiel Ishino; Philip McNab; Kevin Villalobos; Jeffrey H Cohen; Anna M Nápoles; Faustine Williams Journal: Front Public Health Date: 2021-12-20
Authors: Dhuha M B AlDehaini; Suzanne A Al-Bustan; Zainab Hasan Abdulla Malalla; Muhalab E Ali; Mai Sater; Hayder A Giha Journal: Cardiovasc Endocrinol Metab Date: 2020-09-03
Authors: Janet M Wojcicki; Robert H Lustig; Laurie M Jacobs; Ashley E Mason; Alison Hartman; Cindy Leung; Kimber Stanhope; Jue Lin; Laura A Schmidt; Elissa S Epel Journal: Curr Dev Nutr Date: 2021-05-26
Authors: Seyram Kaali; Darby Jack; Jones Opoku-Mensah; Tessa Bloomquist; Joseph Aanaro; Ashlinn Quinn; Ellen Abrafi Boamah-Kaali; Patrick Kinney; Mohammed Nuhu Mujtaba; Oscar Agyei; Abena Konadu Yawson; Samuel Osei-Owusu; Rupert Delimini; Blair Wylie; Kenneth Ayuurebobi Ae-Ngibise; Andrea Baccarelli; Seth Owusu-Agyei; Steven N Chillrud; Kwaku Poku Asante; Alison Lee Journal: Toxics Date: 2021-07-14